Circulating cell-free DNA as a potential biomarker for prediction of disease activity and prognosis among Egyptian rheumatoid arthritis patients
International Journal of Immunopathology and Pharmacology · 2025-01 · 39
DOI: 10.1177/03946320251315036 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Immunopathology and Pharmacology, online erschienen am 31.01.2025. Verfasst von Sara I Taha und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathology, Faculty of Medicine, Ain-Shams University, Cairo, Egypt. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Cell-free DNA (cfDNA) has emerged as a potential biomarker for assessing disease activity and prognosis in rheumatoid arthritis (RA). However, the association between cfDNA levels and the established RA markers of inflammation and disease severity remains unclear. The current study aimed to detect plasma levels of cfDNA in patients with RA and to investigate their association with RA activity indicators (erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), disease activity score-28 (DAS28)), prognostic markers (rheumatoid factor (RF), anticitrullinated protein antibodies (ACPA)), and the musculoskeletal ultrasonographic (US7) scores. This controlled cross-sectional study included 108 RA patients and 108 healthy controls. Plasma levels of cfDNA were quantified by real-time PCR using ALU repeats. Levels of ESR, CRP, RF, and ACPA were measured using routine laboratory assays. Synovial inflammation and joint damage evaluation was performed using the US7 scoring system. Plasma levels of cfDNA were higher in RA patients than controls ( P < 0.001) and significantly increased with higher DAS28 scores among all RA activity groups. Also, cfDNA levels were significantly positively correlated with ESR, CRP, RF, and ACPA levels ( P-values
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pathology, Faculty of Medicine, Ain-Shams University, Cairo, Egypt.
- Department of Internal Medicine, Faculty of Medicine, Ain-Shams University, Cairo, Egypt.
- Department of Physical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, Ain-Shams University, Cairo, Egypt.
- Department of Medical Microbiology and Immunology, Mansoura Faculty of Medicine, Mansoura, Egypt.
- Department of Biochemistry and Molecular Biology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
- Department of Geriatrics medicine and Gerontology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
ORCID-Profile: Sara I Taha, Dalia Hussein Helmy Elsheikh
Zitieren
APA
Taha, S. I., Samaan, S. F., Hawash, S. S., El-Sehsah, E. M., Shamloul, S., Elsheikh, D. H. H., Othman, B., Albanghali, M. A., Aljadani, S. H., Elmanna, A., & Ghorab, R. A. (2025). Circulating cell-free DNA as a potential biomarker for prediction of disease activity and prognosis among Egyptian rheumatoid arthritis patients. International Journal of Immunopathology and Pharmacology, 39. https://doi.org/10.1177/03946320251315036
Vancouver
Taha SI, Samaan SF, Hawash SS, El-Sehsah EM, Shamloul S, Elsheikh DHH, et al. Circulating cell-free DNA as a potential biomarker for prediction of disease activity and prognosis among Egyptian rheumatoid arthritis patients. International Journal of Immunopathology and Pharmacology. 2025;39. doi:10.1177/03946320251315036
BibTeX
@article{Taha2025,
author = {Taha, Sara I and Samaan, Sara F and Hawash, Sally Saber and El-Sehsah, Eman M and Shamloul, Sara and Elsheikh, Dalia Hussein Helmy and Othman, Basim and Albanghali, Mohammad A and Aljadani, Saeedah H and Elmanna, Abdalla and Ghorab, Rasha Ahmed},
title = {Circulating cell-free DNA as a potential biomarker for prediction of disease activity and prognosis among Egyptian rheumatoid arthritis patients},
journal = {International Journal of Immunopathology and Pharmacology},
year = {2025},
volume = {39},
doi = {10.1177/03946320251315036}
}
EUVIMED